Erratum: Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: A double-blind randomized controlled clinical trial (The American Journal of Clinical Nutrition (2013) 98:6 (1425-1432) DOI: 10.3945/ajcn.113.072785);Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: A double-blind randomized controlled clinical trial1-3

American Journal of Clinical Nutrition

Volumn 98, Issue 6, 2013, Pages 1425-1432

  Asemi, Zatollah ^a   Hashemi, Teibeh ^b   Karamali, Maryam ^c   Samimi, Mansooreh ^b   Esmaillzadeh, Ahmad ^d  

^a Research Center for Biochemistry and Nutrition in Metabolic Diseases   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; COLECALCIFEROL; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCIFEDIOL; CHOLECALCIFEROL; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERINSULINISM; INSULIN RESISTANCE; INTENTION TO TREAT ANALYSIS; IRAN; LOST TO FOLLOW-UP; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN D DEFICIENCY;

EID: 84889000071     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.1093/ajcn/nqaa319     Document Type: Erratum

References (51)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(suppl 1):S62-7.
2. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34:173-99.
3. Hossein-Nezhad A, Maghbooli Z, Vassigh AR, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol 2007;46:236-41.
4. Poel YH, Hummel P, Lips P, Stam F, van der Ploeg T, Simsek S. Vitamin D and gestational diabetes: a systematic review and meta-analysis. Eur J Intern Med 2012;23:465-9.
5. Mitanchez D. Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab 2010;36:617-27.
6. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, et al. Summary and recommendations of the Fifth International Workshop - Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(suppl 2): S251-60.
7. Alzaim M, Wood RJ. Vitamin D and gestational diabetes mellitus. Nutr Rev 2013;71:158-67.
8. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011;26:2341-57.
9. Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2013;92:128-39.
10. Mulligan ML, Felton SK, Riek AE, Bernal-Mizrachi C. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2010;202:429e1-9.
11. Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2001 (Epub ahead of print; DOI:10.1186/1471-2350-2-2).
12. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007;30:2569-70.
13. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008;19:50-6.
14. Dantas de Medeiros Rocha E, Dantas Leite L, de Fatima Paiva Baracho M, Goretti do Nascimento Santos M, de Araujo DM, Cavalcante Franca M, da Silva CA, das Gracas Almeida M, Rezende AA, Marchini JS, et al. Effect of diet intervention and oral zinc supplementation on metabolic control in Berardinelli-Seip syndrome. Ann Nutr Metab 2010;57:9-17.
15. Tabesh M, Salehi-Abargouei A, Esmaillzadeh A. Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis. J Clin Endocrinol Metab 2013;98:3165-73.
16. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010;39:419-46.
17. Wehmeier K, Beers A, Haas MJ, Wong NC, Steinmeyer A, Zugel U, Mooradian AD. Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta 2005;1737:16-26.
18. Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, LightRP, Agarwal R. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension2008;52:249-55.
19. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 2013 (Epub ahead of print; DOI:10.1186/1758-5996-5-8).
20. Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med 2013;24:644-9.
21. Hosseinzadeh-Shamsi-Anar M, Mozaffari-Khosravi H, Salami MA, Hadinedoushan H, Mozayan MR. The efficacy and safety of a high dose of vitamin d in mothers with gestational diabetes mellitus: a randomized controlled clinical trial. Iran J Med Sci 2012;37:159-65.
22. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr 2004 20;4:14.
23. Rossi G. [Diagnosis and classification of diabetes mellitus.] Recenti Prog Med 2010;101:274-6 (in Italian).
24. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.Diabetes Care 2013;36:845-53.
25. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem1996;239:70-6.
26. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985;105:581-4.
27. Bener A, Saleh NM, Al-Hamaq A. Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons. Int J Womens Health 2011;3:367-73
28. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003;102:857-68.
29. Jelsema RD. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2004;103:586; author reply: 586-7
30. Linné Y, Barkeling B, Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002;109:1227-31.
31. Senti J, Thiele DK, Anderson CM. Maternal vitamin D status as a critical determinant in gestational diabetes. J Obstet Gynecol NeonatalNurs 2012;41:328-38.
32. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementationreduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - A randomised,placebo-controlled trial. Br J Nutr 2010;103:549-55.
33. Asemi Z, Samimi M, Tabassi Z, Shakeri H, Esmaillzadeh A. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 2013;143:1432-8.
34. Soheilykhah S, Mojibian M, Moghadam MJ, Shojaoddiny-Ardekani A. The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy. Gynecol Endocrinol 2013;29:396-9.
35. Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Amiri F. Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebocontrolled clinical trial. Diabet Med 2013 (Epub ahead of print; DOI: 10.1111/dme.12273).
36. Maestro B, Molero S, Bajo S, Davila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct 2002;20:227-32.
37. Stentz FB, Kitabchi AE. Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 2007;5:216-35.
38. Longenecker CT, Hileman CO, Carman TL, Ross AC, Seydafkan S, Brown TT, Labbato DE, Storer N, Tangpricha V, McComsey GA. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 2012;17:613-21.
39. Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 2012(Epub ahead of print; DOI:10.1186/1475-2840-11- 85).
40. Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 2012 (Epub ahead of print; DOI: 10.1186/1476-511X-11-42).
41. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267:462-72.
42. Kaplan M, Kerry R, Aviram M, Hayek T. High glucose concentration increases macrophage cholesterol biosynthesis in diabetes throughactivation of the sterol regulatory element binding protein 1 (SREBP1):inhibitory effect of insulin. J Cardiovasc Pharmacol 2008;52:324-32.
43. Jorde R, Strand Hutchinson M, Kjaergaard M, Sneve M, Grimnes G. Supplementation with high doses of vitamin D to subjects without vitamin D deficiency may have negative effects: pooled data from four intervention trials in Tromso. ISRN Endocrinol 2013 (Epub ahead ofprint; DOI:10.1155/2013/348705).
44. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N,Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS ONE 2012;7:e36617.
45. Carrillo AE, Flynn MG, Pinkston C, Markofski MM, Jiang Y, DonkinSS, Teegarden D. Vitamin D supplementation during exercise trainingdoes not alter inflammatory biomarkers in overweight and obese subjects. Eur J Appl Physiol 2012;112:3045-52.
46. Eleftheriadis T, Antoniadi G, Liakopoulos V, Stefanidis I, Galaktidou G. Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. Iran J Kidney Dis 2012;6:129-35.
47. O'Hartaigh B, Thomas GN, Silbernagel G, Bosch JA, Pilz S, Loerbroks A, Kleber ME, Grammer TB, Bohm BO, Marz W. Association of 25-hydroxyvitamin D with type 2 diabetes among patients undergoing coronary angiography: cross-sectional findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Clin Endocrinol (Oxf) 2013;79:192-8.
48. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012;109:226-30.
49. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW,Wong LY, Lee SW, Tam S, Wong EW, Lau CP, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013;227:140-6.
50. Ekici F, Ozyurt B, Erdogan H. The combination of vitamin D3 and dehydroascorbic acid administration attenuates brain damage in focal ischemia. Neurol Sci 2009;30:207-12.
51. Fedirko V, Bostick RM, Long Q, Flanders WD, McCullough ML, Sidelnikov E, Daniel CR, Rutherford RE, Shaukat A. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer EpidemiolBiomarkers Prev 2010;19:280-91